Completed OBSERVATIONAL NCT01878981

Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China

Sponsor: Johnson & Johnson Medical, China

Updated 7 times since 2017 Last updated: Nov 13, 2019 Started: Jun 30, 2011 Primary completion: Nov 23, 2013 Completion: Nov 23, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atrial Fibrillation and is currently completed. Johnson & Johnson Medical, China leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2019 — Jan 2021 [monthly]

Completed

Status: Unknown Status → Completed
Jun 2018 — Dec 2019 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johnson & Johnson Medical, China

Data source: Johnson & Johnson Medical, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.